Physician profile
Tracy Perry
NPI 1295137651
$13,863.44
in general payments reported to CMS, 2019-2025
49 companies · $2,724 in 2025
The $2,724 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,737 · 2022: $2,172 · 2023: $3,081 · 2024: $3,149 · 2025: $2,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,933 · Education: $22.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,932.53 |
| Education | $22.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,282.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $2,024.16 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $1,360.52 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Xeris Pharmaceuticals, INC. | $1,254.26 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Intuitive Surgical, INC. | $1,127.58 | 2021 | |
| Dexcom, INC. | $715.87 | 2021-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $470.32 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $469.86 | 2021-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $409.22 | 2021-2025 | |
| Amgen INC. | $332.46 | 2021-2025 | Tepezza, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $295.59 | 2021-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $246.82 | 2022-2025 | |
| Cequr Corporation | $201.63 | 2022-2024 | Cequr Simplicity |
| Radius Health, INC. | $201.25 | 2021-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $199.46 | 2021-2024 | Unithroid |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $197.68 | 2021-2025 | Korlym |
| Mannkind Corporation | $191.40 | 2021-2025 | |
| Sequel Med Tech, LLC | $182.84 | 2025 | Twiist |
| Abbvie INC. | $145.02 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.65 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Ascendis Pharma Endocrinology INC | $123.78 | 2023-2025 | Yorvipath |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.76 | 2021-2023 | Cycloset |
| Horizon Therapeutics Plc | $96.95 | 2021-2023 | Tepezza |
| Ibsa Pharma INC. | $96.86 | 2021-2025 | Licart, Tirosint, Flector |
| Masimo Corporation | $94.45 | 2022 | |
| Ascensia Diabetes Care US INC. | $83.67 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $82.07 | 2022-2025 | Strensiq |
| Beta Bionics, INC. | $74.75 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Recordati_rare_diseases_inc. | $73.10 | 2024-2025 | Isturisa, Signifor Lar |
| Madrigal Pharmaceuticals | $57.50 | 2025 | Rezdiffra |
| Embecta Corp. | $57.15 | 2024 | Bd Nano 2nd Gen Pen Needle |
| Becton, Dickinson and Company | $52.60 | 2021-2022 | |
| Amphastar Pharmaceuticals, INC. | $48.47 | 2024-2025 | |
| Amarin Pharma, INC. | $47.61 | 2021 | |
| Vivus LLC | $42.92 | 2021-2023 | Qsymia |
| Lifescan, INC. | $38.44 | 2022-2023 | |
| Acella Pharmaceuticals, LLC | $35.96 | 2023-2025 | NP Thyroid 60 |
| Verity Pharmaceuticals INC. | $29.18 | 2024 | Tlando |
| Esperion Therapeutics, INC. | $22.85 | 2023 | Nexletol |
| Theracosbio, LLC | $16.76 | 2024 | Brenzavvy |
| Organon LLC | $16.06 | 2025 | |
| Pfizer INC. | $14.97 | 2022 | |
| Currax Pharmaceuticals LLC | $14.74 | 2021 | |
| Averitas Pharma INC. | $14.69 | 2023 | Qutenza |
| Silk Road Medical, INC. | $14.47 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Ionis Pharmaceuticals, INC. | $14.45 | 2025 | Tryngolza |
| Amryt Pharma Holdings LTD | $13.55 | 2023 | Myalept |
| Grt US Holding, INC. | $11.64 | 2022 | |
| Medtronic, INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.